On August 13, 2025, BioTAG from Israel visited AtaGenix’s Wuhan headquarters to discuss antibody drug development, protein engineering, and CRO services. The collaboration aims to advance precision medicine and biopharmaceutical innovation globally.
AtaGenix will participate in LAB International 2025, taking place in Thailand from September 3 to 5, 2025. Visit Booth 2S21 to explore our capabilities in antibody discovery, engineering, protein expression, and purification, as well as the abinScience portfolio of recombinant proteins and antibodies. Let’s connect and discuss potential collaborations.
